Phlox Therapeutics raises €1.9M to advance RNA therapies for rare heart diseases
December 11, 2024Phlox Therapeutics, a biotechnology spin-off from Amsterdam UMC, has secured €1.9 million in seed funding to accelerate the development of RNA-based therapies for rare genetic heart conditions. This funding brings Phlox closer to delivering life-changing treatments for patients with genetic laminopathies, a critical unmet need in cardiovascular health.
This round of funding adds ROM Utrecht Region to the existing syndicate of FIRST fund, Amsterdam UMC Venture Holding, and Utrecht Health Seed Fund (USHF). With their backing, Phlox is set to advance its lead program through preclinical development. Supported by IXA and AMC Ventures Holding, prof. dr. Pinto founded the company in 2022, together with prof. dr. Eva van Rooij and with Margien Boels, PhD as its initiating business director.
The investment marks an important milestone for Phlox Therapeutics, as it continues to pioneer new RNA-based approaches to treat rare cardiovascular conditions. Phlox: “With this funding, we are energized to make substantial strides toward developing new treatment options that could transform the lives of those affected by cardiomyopathies.”
- Full press release on Phlox’ website
More news
Start-up VU-AMS has big plans with clever stress monitoring device
VU-AMS is on a mission to revolutionize how we understand and manage stress-related health issues. Now an official VU spin-off, there are big plans for clinical applications. Founder of VU AMS Martin Gevonden explains: “We offer researchers autonomic biomarkers that are valid, reliable and easy to use, without getting under the skin.” After thriving in […]
News
PULSE Sport Wins Prestigious Dutch Sports Innovation Award 2024
PULSE Sport, a start-up from the Demonstrator Lab, has reached a significant milestone by winning the prestigious 14th Dutch Sports Innovation Award. The company’s flagship product, a cutting-edge athlete management system, integrates advanced software and artificial intelligence to revolutionize athlete health and performance monitoring. About the Innovation PULSE Sport’s athlete management system provides a holistic […]
News
Biotech boost(er) for life sciences innovations
Amsterdam researchers have secured Biotech Booster funding for a total of six projects, that include a promising cancer treatment, a new diagnostic method for Alzheimer’s Disease, an implant helping blindness, lab innovation in biotechnology, and a nutritional intervention for mental health. The researchers will develop a solid business case for their innovations in the time […]
News